Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paramit Chowdhury

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|April 10, 2009
Percutaneous renal biopsyJoble Joseph, Paramit Chowdhury
Current Opinion in Organ Transplantation|January 4, 2013
Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approachParamit Chowdhury, Maria P Hernandez-Fuentes
Current Opinion in Nephrology and Hypertension|October 24, 2002
Footprints of humoral rejectionSteven H Sacks, Paramit Chowdhury
Current Opinion in Immunology|September 23, 2003
Role of the complement system in rejectionSteven H Sacks, Paramit Chowdhury, Wuding Zhou
Kidney International|October 2, 2004
Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infectionParamit Chowdhury, Steven H Sacks, Neil S Sheerin
Nephron. Experimental Nephrology|April 29, 2010
Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstructionParamit Chowdhury, Steven Howard Sacks, Neil Stephen Sheerin
Ebiomedicine|April 2, 2019
Gene expression biomarkers for kidney transplant rejection-The entire landscape-Author's replySofia Christakoudi, Manohursingh Runglall, Paramit Chowdhury, et al.
Transplantation|February 9, 2005
Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathyBehdad Afzali, Sapna Shah, Paramit Chowdhury, et al.
Transplantation Reviews (Orlando, Fla.)|April 11, 2025
Advances in biomarkers of acute allograft rejection and interstitial fibrosis/tubular atrophy in kidney transplantation; future perspective and challenges in clinical implementationTanguy Lafont, Subhankar Mukhopadhyay, Sohani N Dassanayake, et al.
Kidney International Reports|April 14, 2021
IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on HemodialysisCaroline Dudreuilh, Tayeba Roper, Cormac Breen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Hospital Medicine (London, England : 2005)|April 10, 2009
Percutaneous renal biopsyJoble Joseph, Paramit Chowdhury
Current Opinion in Organ Transplantation|January 4, 2013
Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approachParamit Chowdhury, Maria P Hernandez-Fuentes
Current Opinion in Nephrology and Hypertension|October 24, 2002
Footprints of humoral rejectionSteven H Sacks, Paramit Chowdhury
Current Opinion in Immunology|September 23, 2003
Role of the complement system in rejectionSteven H Sacks, Paramit Chowdhury, Wuding Zhou
Kidney International|October 2, 2004
Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infectionParamit Chowdhury, Steven H Sacks, Neil S Sheerin
Nephron. Experimental Nephrology|April 29, 2010
Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstructionParamit Chowdhury, Steven Howard Sacks, Neil Stephen Sheerin
Ebiomedicine|April 2, 2019
Gene expression biomarkers for kidney transplant rejection-The entire landscape-Author's replySofia Christakoudi, Manohursingh Runglall, Paramit Chowdhury, et al.
Transplantation|February 9, 2005
Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathyBehdad Afzali, Sapna Shah, Paramit Chowdhury, et al.
Transplantation Reviews (Orlando, Fla.)|April 11, 2025
Advances in biomarkers of acute allograft rejection and interstitial fibrosis/tubular atrophy in kidney transplantation; future perspective and challenges in clinical implementationTanguy Lafont, Subhankar Mukhopadhyay, Sohani N Dassanayake, et al.
Kidney International Reports|April 14, 2021
IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on HemodialysisCaroline Dudreuilh, Tayeba Roper, Cormac Breen, et al.
Pageof 3